Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Golden Cariboo (CSE:GCC) (OTC:GCCFF) Expands Gold Footprint in BC (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Celldex Therapeutics Inc
CLDX
Healthcare
Biotechnology
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases. The company’s drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases for which available treatments are inadequate. Its clinical development programs are...
Barzolvolimab (CDX-0159), a monoclonal antibody that specifically binds the KIT receptor and potently inhibits its activity for treating chronic urticarias, prurigo nodularis, eosinophilic esophagitis, and atopic dermatitis; and CDX-622, a bispecific candidate for inflammatory diseases, which targets two complementary pathways that drive chronic inflammation, potently neutralizing the alarmin thymic stromal lymphopoietin and depleting mast cells through stem cell factor starvation. The company is headquartered in Hampton, New Jersey.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (NDAQ:CLDX)
New Post
View:
Posts & Comments
Threaded Posts
(1)
•••
paths
X
Post by
paths
on Jun 17, 2020 3:31am
Woo-ho
Finally, a rally, a trend change, and the company coming back to life...!
(187)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Feb 21, 2020 10:40am
it's a sell today for me
at.$3.27 per share,it's been over a year for me with this one and it's time to take my profits out.
(187)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Feb 18, 2019 9:09pm
this stock
should do well this year for me,so glta shareholders buying it at these low prices.
(187)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Feb 06, 2019 10:51am
forming a head & shoulders pattern
which is a really good chart for this one,so glta.
(187)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Jan 02, 2019 4:09pm
climb up starts today for me
so glta shareholders.
(187)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Dec 07, 2018 2:32pm
added more of this one
at these low prices,averaging my costs down,so glta.
(187)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Nov 28, 2018 2:00pm
flat lining right now
should stay steady at this price for a while,so glta.
(187)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Nov 27, 2018 11:45am
it's a buy today for me
it is at the bottom,so glta shareholders, as it is a big bargain for me at these prices and usually,if you can get some stock that is trading at about 10 % of its high for the year , you will do well
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
New Gold Opportunities in the Cariboo Region (CSE:GCC) (OTC:GCCFF)
Podcasts